Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.L. Sullivan.
Iron and the sex difference in heart disease risk.
Lancet, 1 (1981), pp. 1293-1294
[2.]
J. Swain, J.M. Gutteridge.
Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material.
FEBS Lett, 368 (1995), pp. 513-515
[3.]
J.T. Salonen, K. Nyyssonen, H. Korpela, J. Tuomilehto, R. Seppanen, R. Salonen.
High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.
Circulation, 86 (1992), pp. 803-811
[4.]
S. Kiechl, F. Aichner, F. Gerstenbrand, G. Egger, A. Mair, G. Rungger, et al.
Body iron stores and presence of carotid atherosclerosis: results from the Bruneck study.
Arterioscler Thromb, 14 (1994), pp. 1625-1630
[5.]
S.V. Shah, M.G. Alam.
Role of iron in atherosclerosis.
Am J Kidney Dis, 41 (2003), pp. 80-83
[6.]
T.P. Tuomainen, K. Punnonen, K. Nyysonen, J.T. Salonen.
Association between body iron stores and the risk of myocardial infarction in men.
Circulation, 97 (1998), pp. 1461-1466
[7.]
J. Danesh, P. Appleby.
Coronary heart disease and iron status. Meta-analyses of prospective studies.
Circulation, 99 (1999), pp. 852-854
[8.]
R.B. Lauffer.
Iron stores and the international variation in mortality from coronary artery disease.
Med Hypotheses, 35 (1991), pp. 96-102
[9.]
M. Roest, Y.T. Van der Schouw, J.J. Marx, et al.
Heterozygosity for a hemocromatosis gene is associated with cardiovascular health in women.
Circulation, 100 (1999), pp. 1268-1273
[10.]
J.T. Salonen, T.P. Tuomainen, R. Salonen, et al.
Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study.
Am J Epidemiol, 148 (1998), pp. 448-451
[11.]
M. Moore, A.R. Folsom, R.W. Bames, J.H. Eckfeldt.
No association between serum ferritin and aymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study.
Am J Epidemiol, 141 (1995), pp. 719-723
[12.]
J.E. Eichner, H. Qi, W.E. Moore, E. Sechter.
Iron measures in coronary angiography patients.
Atherosclerosis, 136 (1998), pp. 241-245
[13.]
M. Miller, G.M. Hutchins.
Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease.
Jama, 272 (1994), pp. 231-233
[14.]
E.A. Kirk, J.W. Einecke, R.C. LeBoeuf.
Iron overload diminishes atherosclerosis in apoE-deficient mice.
J Clin Invest, 107 (2001), pp. 1545-1553
[15.]
A. Paul, L. Calleja, J. Camps, J. Osada, E. Vilella, N. Ferre, et al.
The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice.
Life Sci, 68 (2000), pp. 457-465
[16.]
M. Tous, N. Ferre, E. Vilella, F. Riu, J. Camps, J. Joven.
Circulating blood cells modulate the atherosclerotic process in apolipoprotein E-deficient mice.
Metabolism, 53 (2004), pp. 95-100
[17.]
J.L. Sullivan.
Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis.
Am Heart J, 145 (2003), pp. 190-194
Copyright © 2003. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.